The program will address:
- Update on the status of Dodd-Frank rules applicable to proxy statements
- Update on proxy access and shareholder proposals
- Compensation consultant independence and disclosure
- Compensation committee independence
- Pledging and clawback policies
- Impact of voting policy updates from the major proxy advisory firms
- Update on say-on-pay
Panelists include:
- Peter D. Fetzer, Foley & Lardner LLP
- Richard H Grubaugh, D.F. King & Co., Inc.
- Joshua A. Agen, Foley & Lardner LLP
There is no cost to participate in this program, but pre-registration is required. For more information, please contact Jennifer Bartz at [email protected].
Foley & Lardner LLP will apply for CLE credit after the program, wherever applicable. Foley & Lardner LLP certifies that this activity has been approved for California MCLE credits by the State Bar of California in the amount of one General credit. Foley & Lardner LLP is a State Bar of California MCLE approved provider. Please note that participants must log in to both the teleconference and LiveMeeting portions on the date of the event; credit may not be obtained by viewing and/or listening to a program recording after the event.
People
Related Insights
May 22, 2026
Foley Viewpoints
New Lawsuit Tests the Limits of Donor-Advised Fund Advisory Privileges
A recent lawsuit seeking to clarify the extent of an advisor’s privileges with respect to a donor-advised fund (DAF) has been filed in…
May 22, 2026
Energy Current
FERC Just Rewrote the Rules for Natural Gas Infrastructure. Here’s What It Means.
Yesterday’s unanimous FERC vote is the most significant natural gas permitting reform in two decades — and its practical implications…
May 22, 2026
Foley Viewpoints
What the Federal Circuit’s Poultry Patent Ruling Says About 'About'
The decision does not appear to prohibit the use of terms such as "about" or "approximately." Rather, it reinforces that such terms may be acceptable where the patent record provides sufficient context for understanding the scope of the claimed range.